Improved efficacy and in vivo cellular properties of human embryonic stem cell derivative in a preclinical model of bladder pain syndrome
Abstract Interstitial cystitis/bladder pain syndrome (IC/BPS) is an intractable disease characterized by severe pelvic pain and urinary frequency. Mesenchymal stem cell (MSC) therapy is a promising approach to treat incurable IC/BPS. Here, we show greater therapeutic efficacy of human embryonic stem...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6d4a5c86dae849c1b92c8adbad8ea9a7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:6d4a5c86dae849c1b92c8adbad8ea9a7 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:6d4a5c86dae849c1b92c8adbad8ea9a72021-12-02T15:05:16ZImproved efficacy and in vivo cellular properties of human embryonic stem cell derivative in a preclinical model of bladder pain syndrome10.1038/s41598-017-09330-x2045-2322https://doaj.org/article/6d4a5c86dae849c1b92c8adbad8ea9a72017-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-09330-xhttps://doaj.org/toc/2045-2322Abstract Interstitial cystitis/bladder pain syndrome (IC/BPS) is an intractable disease characterized by severe pelvic pain and urinary frequency. Mesenchymal stem cell (MSC) therapy is a promising approach to treat incurable IC/BPS. Here, we show greater therapeutic efficacy of human embryonic stem cell (hESC)-derived multipotent stem cells (M-MSCs) than adult bone-marrow (BM)-derived counterparts for treating IC/BPS and also monitor long-term safety and in vivo properties of transplanted M-MSCs in living animals. Controlled hESC differentiation and isolation procedures resulted in pure M-MSCs displaying typical MSC behavior. In a hydrochloric-acid instillation-induced IC/BPS animal model, a single local injection of M-MSCs ameliorated bladder symptoms of IC/BPS with superior efficacy compared to BM-derived MSCs in ameliorating bladder voiding function and histological injuries including urothelium denudation, mast-cell infiltration, tissue fibrosis, apoptosis, and visceral hypersensitivity. Little adverse outcomes such as abnormal growth, tumorigenesis, or immune-mediated transplant rejection were observed over 12-months post-injection. Intravital confocal fluorescence imaging tracked the persistence of the transplanted cells over 6-months in living animals. The infused M-MSCs differentiated into multiple cell types and gradually integrated into vascular-like structures. The present study provides the first evidence for improved therapeutic efficacy, long-term safety, and in vivo distribution and cellular properties of hESC derivatives in preclinical models of IC/BPS.Aram KimHwan Yeul YuJisun LimChae-Min RyuYong Hwan KimJinbeom HeoJu-Young HanSeungun LeeYoon Sung BaeJae Young KimDong-Jun BaeSang-Yeob KimByeong-Joo NohKi-Sung HongJi-Yeon HanSang Wook LeeMiho SongHyung-Min ChungJun Ki KimDong-Myung ShinMyung-Soo ChooNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-16 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Aram Kim Hwan Yeul Yu Jisun Lim Chae-Min Ryu Yong Hwan Kim Jinbeom Heo Ju-Young Han Seungun Lee Yoon Sung Bae Jae Young Kim Dong-Jun Bae Sang-Yeob Kim Byeong-Joo Noh Ki-Sung Hong Ji-Yeon Han Sang Wook Lee Miho Song Hyung-Min Chung Jun Ki Kim Dong-Myung Shin Myung-Soo Choo Improved efficacy and in vivo cellular properties of human embryonic stem cell derivative in a preclinical model of bladder pain syndrome |
description |
Abstract Interstitial cystitis/bladder pain syndrome (IC/BPS) is an intractable disease characterized by severe pelvic pain and urinary frequency. Mesenchymal stem cell (MSC) therapy is a promising approach to treat incurable IC/BPS. Here, we show greater therapeutic efficacy of human embryonic stem cell (hESC)-derived multipotent stem cells (M-MSCs) than adult bone-marrow (BM)-derived counterparts for treating IC/BPS and also monitor long-term safety and in vivo properties of transplanted M-MSCs in living animals. Controlled hESC differentiation and isolation procedures resulted in pure M-MSCs displaying typical MSC behavior. In a hydrochloric-acid instillation-induced IC/BPS animal model, a single local injection of M-MSCs ameliorated bladder symptoms of IC/BPS with superior efficacy compared to BM-derived MSCs in ameliorating bladder voiding function and histological injuries including urothelium denudation, mast-cell infiltration, tissue fibrosis, apoptosis, and visceral hypersensitivity. Little adverse outcomes such as abnormal growth, tumorigenesis, or immune-mediated transplant rejection were observed over 12-months post-injection. Intravital confocal fluorescence imaging tracked the persistence of the transplanted cells over 6-months in living animals. The infused M-MSCs differentiated into multiple cell types and gradually integrated into vascular-like structures. The present study provides the first evidence for improved therapeutic efficacy, long-term safety, and in vivo distribution and cellular properties of hESC derivatives in preclinical models of IC/BPS. |
format |
article |
author |
Aram Kim Hwan Yeul Yu Jisun Lim Chae-Min Ryu Yong Hwan Kim Jinbeom Heo Ju-Young Han Seungun Lee Yoon Sung Bae Jae Young Kim Dong-Jun Bae Sang-Yeob Kim Byeong-Joo Noh Ki-Sung Hong Ji-Yeon Han Sang Wook Lee Miho Song Hyung-Min Chung Jun Ki Kim Dong-Myung Shin Myung-Soo Choo |
author_facet |
Aram Kim Hwan Yeul Yu Jisun Lim Chae-Min Ryu Yong Hwan Kim Jinbeom Heo Ju-Young Han Seungun Lee Yoon Sung Bae Jae Young Kim Dong-Jun Bae Sang-Yeob Kim Byeong-Joo Noh Ki-Sung Hong Ji-Yeon Han Sang Wook Lee Miho Song Hyung-Min Chung Jun Ki Kim Dong-Myung Shin Myung-Soo Choo |
author_sort |
Aram Kim |
title |
Improved efficacy and in vivo cellular properties of human embryonic stem cell derivative in a preclinical model of bladder pain syndrome |
title_short |
Improved efficacy and in vivo cellular properties of human embryonic stem cell derivative in a preclinical model of bladder pain syndrome |
title_full |
Improved efficacy and in vivo cellular properties of human embryonic stem cell derivative in a preclinical model of bladder pain syndrome |
title_fullStr |
Improved efficacy and in vivo cellular properties of human embryonic stem cell derivative in a preclinical model of bladder pain syndrome |
title_full_unstemmed |
Improved efficacy and in vivo cellular properties of human embryonic stem cell derivative in a preclinical model of bladder pain syndrome |
title_sort |
improved efficacy and in vivo cellular properties of human embryonic stem cell derivative in a preclinical model of bladder pain syndrome |
publisher |
Nature Portfolio |
publishDate |
2017 |
url |
https://doaj.org/article/6d4a5c86dae849c1b92c8adbad8ea9a7 |
work_keys_str_mv |
AT aramkim improvedefficacyandinvivocellularpropertiesofhumanembryonicstemcellderivativeinapreclinicalmodelofbladderpainsyndrome AT hwanyeulyu improvedefficacyandinvivocellularpropertiesofhumanembryonicstemcellderivativeinapreclinicalmodelofbladderpainsyndrome AT jisunlim improvedefficacyandinvivocellularpropertiesofhumanembryonicstemcellderivativeinapreclinicalmodelofbladderpainsyndrome AT chaeminryu improvedefficacyandinvivocellularpropertiesofhumanembryonicstemcellderivativeinapreclinicalmodelofbladderpainsyndrome AT yonghwankim improvedefficacyandinvivocellularpropertiesofhumanembryonicstemcellderivativeinapreclinicalmodelofbladderpainsyndrome AT jinbeomheo improvedefficacyandinvivocellularpropertiesofhumanembryonicstemcellderivativeinapreclinicalmodelofbladderpainsyndrome AT juyounghan improvedefficacyandinvivocellularpropertiesofhumanembryonicstemcellderivativeinapreclinicalmodelofbladderpainsyndrome AT seungunlee improvedefficacyandinvivocellularpropertiesofhumanembryonicstemcellderivativeinapreclinicalmodelofbladderpainsyndrome AT yoonsungbae improvedefficacyandinvivocellularpropertiesofhumanembryonicstemcellderivativeinapreclinicalmodelofbladderpainsyndrome AT jaeyoungkim improvedefficacyandinvivocellularpropertiesofhumanembryonicstemcellderivativeinapreclinicalmodelofbladderpainsyndrome AT dongjunbae improvedefficacyandinvivocellularpropertiesofhumanembryonicstemcellderivativeinapreclinicalmodelofbladderpainsyndrome AT sangyeobkim improvedefficacyandinvivocellularpropertiesofhumanembryonicstemcellderivativeinapreclinicalmodelofbladderpainsyndrome AT byeongjoonoh improvedefficacyandinvivocellularpropertiesofhumanembryonicstemcellderivativeinapreclinicalmodelofbladderpainsyndrome AT kisunghong improvedefficacyandinvivocellularpropertiesofhumanembryonicstemcellderivativeinapreclinicalmodelofbladderpainsyndrome AT jiyeonhan improvedefficacyandinvivocellularpropertiesofhumanembryonicstemcellderivativeinapreclinicalmodelofbladderpainsyndrome AT sangwooklee improvedefficacyandinvivocellularpropertiesofhumanembryonicstemcellderivativeinapreclinicalmodelofbladderpainsyndrome AT mihosong improvedefficacyandinvivocellularpropertiesofhumanembryonicstemcellderivativeinapreclinicalmodelofbladderpainsyndrome AT hyungminchung improvedefficacyandinvivocellularpropertiesofhumanembryonicstemcellderivativeinapreclinicalmodelofbladderpainsyndrome AT junkikim improvedefficacyandinvivocellularpropertiesofhumanembryonicstemcellderivativeinapreclinicalmodelofbladderpainsyndrome AT dongmyungshin improvedefficacyandinvivocellularpropertiesofhumanembryonicstemcellderivativeinapreclinicalmodelofbladderpainsyndrome AT myungsoochoo improvedefficacyandinvivocellularpropertiesofhumanembryonicstemcellderivativeinapreclinicalmodelofbladderpainsyndrome |
_version_ |
1718388895398232064 |